Powered by: Motilal Oswal
2026-09-02 04:37:49 pm | Source: Accord Fintech
Mankind Pharma gains on BSE
Mankind Pharma gains on BSE

Mankind Pharma is currently trading at Rs. 2372.00, up by 12.00 points or 0.51% from its previous closing of Rs. 2360.00 on the BSE.

The scrip opened at Rs. 2323.15 and has touched a high and low of Rs. 2382.50 and Rs. 2323.15 respectively. So far 10618 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 2670.00 on 19-Sep-2025 and a 52 week low of Rs. 1909.90 on 23-Mar-2026.

Last one week high and low of the scrip stood at Rs. 2441.15 and Rs. 2,323.15 respectively. The current market cap of the company is Rs. 97612.88 crore.

The promoters holding in the company stood at 72.63%, while Institutions and Non-Institutions held 24.80% and 2.57% respectively.

Mankind Pharma has sold its 100% stake held in Broadway Hospitality Services (Broadway) to AKRK Projects LLP and its Partners. Post this transaction, Broadway has ceased to be a wholly owned subsidiary of the company with effect from August 31, 2026.

Earlier, the Board of Directors of the company, at its meeting held on July 11, 2026, had approved the divestment of 100% stake held in Broadway for a consideration of Rs 49.00 crore.

Disclaimer: The content of this article is for informational purposes only and should not be considered financial or investment advice. Investments in financial markets are subject to market risks, and past performance is not indicative of future results. Readers are strongly advised to consult a licensed financial expert or advisor for tailored advice before making any investment decisions. The data and information presented in this article may not be accurate, comprehensive, or up-to-date. Readers should not rely solely on the content of this article for any current or future financial references. To Read Complete Disclaimer Click Here